Trial reportThe journals of gerontology. Series A, Biological sciences and medical sciences2026
Effects of inhaled aromatherapy on sleep quality and cognitive function in older adults: a randomised controlled trial.
Trial report in The journals of gerontology. Series A, Biological sciences and medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06208800 (Effects of Inhaled Blend Aromatherapy on Sleep Duration, Sleep Quality, Time to Fall Asleep and Cognitive Level in Elderly People), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Inhaled Blend Aromatherapy on Sleep Duration, Sleep Quality, Time to Fall Asleep and Cognitive Level in Elderly People
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundSleep disturbances and cognitive decline frequently coexist in older adults and are associated with adverse health outcomes. Aromatherapy has emerged as a potential non-pharmacological intervention; however, evidence from inhalation-based protocols integrating both subjective and objective sleep assessments remains limited.
methodsThis single-blind, randomised controlled trial was conducted in a residential care facility in Istanbul between January and June 2024. Sixty participants aged ≥65 years were randomly allocated to an intervention group (n = 30) or a control group (n = 30). The intervention consisted of inhaling a peppermint-palmarosa blend in the morning and a nighttime blend of vetiver, cedarwood, clary sage, petitgrain, and grapefruit oils for 10 minutes daily over 30 days. Outcomes included the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and Blessed Orientation-Memory-Concentration Test, alongside objective sleep parameters obtained from Oppo Watch Free wearable smartwatches using photoplethysmography and accelerometer-based algorithms.
resultsCompared with the control group, the intervention group demonstrated significant improvements in total sleep time (d = 1.29), Rapìd Eye Movement (REM) sleep duration (d = 1.34), and deep sleep (N3) duration (d = 1.47), along with reduced sleep latency (d = -1.12) (all p < .001). Daytime sleepiness decreased, and subjective sleep quality improved. Cognitive performance also improved, with significant gains observed in orientation, memory, and concentration, whereas no significant changes were observed in the control group.
conclusionsA circadian-aligned, multicomponent inhalation aromatherapy protocol may represent a feasible and clinically relevant complementary intervention to improve sleep architecture and cognitive outcomes in older adults residing in residential care settings. CLINICAL TRIAL REGISTRATION NUMBER: NCT06208800.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.